GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Stella Diagnostics Inc (OTCPK:SLDX) » Definitions » Earnings per Share (Diluted)

Stella Diagnostics (Stella Diagnostics) Earnings per Share (Diluted) : $ (TTM As of Sep. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Stella Diagnostics Earnings per Share (Diluted)?

Stella Diagnostics's Earnings per Share (Diluted) for the three months ended in Sep. 2023 was $-0.00.

Stella Diagnostics's EPS (Basic) for the three months ended in Sep. 2023 was $-0.00.

Stella Diagnostics's EPS without NRI for the three months ended in Sep. 2023 was $-0.00.


Stella Diagnostics Earnings per Share (Diluted) Historical Data

The historical data trend for Stella Diagnostics's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stella Diagnostics Earnings per Share (Diluted) Chart

Stella Diagnostics Annual Data
Trend
Earnings per Share (Diluted)

Stella Diagnostics Quarterly Data
Sep22 Sep23
Earnings per Share (Diluted) -0.01 -

Competitive Comparison of Stella Diagnostics's Earnings per Share (Diluted)

For the Diagnostics & Research subindustry, Stella Diagnostics's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stella Diagnostics's PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Stella Diagnostics's PE Ratio distribution charts can be found below:

* The bar in red indicates where Stella Diagnostics's PE Ratio falls into.



Stella Diagnostics Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

Stella Diagnostics's Earnings Per Share (Diluted) for the fiscal year that ended in . 20 is calculated as

Diluted Earnings Per Share (A: . 20 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-)/0
=

Stella Diagnostics's Earnings Per Share (Diluted) for the quarter that ended in Sep. 2023 is calculated as

Diluted Earnings Per Share (Q: Sep. 2023 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(-0.816-0)/401.600
=-0.00

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.


Stella Diagnostics  (OTCPK:SLDX) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Stella Diagnostics Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of Stella Diagnostics's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Stella Diagnostics (Stella Diagnostics) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
50 West Broadway, Suite 300, Salt Lake City, UT, USA, 84104
Stella Diagnostics Inc is a molecular diagnostics-based organization focused on improving patient management strategies for people living with severe esophageal disease. It is developing first-line diagnostic tools that provide superior molecular information for providers as compared to the current standard screening protocols.

Stella Diagnostics (Stella Diagnostics) Headlines

From GuruFocus